For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Endovascular Thrombectomy Plus Medical Management | Endovascular Thrombectomy: Patients will receive thrombectomy plus medical management. Treated with thrombectomy devices (stent-retrievers or aspiration devices) currently cleared by the FDA for thrombus removal in patients experiencing an acute stroke within 24 hours of symptom onset. The devices used are FDA-approved: Trevo Retriever, the Solitaire Revascularization Device, EmboTrap Revascularization Device and Tigertriever Revascularization Device; and/or the aspiration devices approved by the FDA (e.g. MicroVention SOFIA Catheter, and the Penumbra thrombectomy system). The choice of thrombectomy method, primary approach/technique, whether primary aspiration or primary stent-retriever with/without aspiration, is left up to the interventionalist. Medical Management: Patients receive AHA guideline-directed medical therapy- includes IV thrombolytic therapy for use according to practice guidelines in patients presenting within the first 3 hours from last-seen-normal and meeting other FDA label criteria, or up to 4.5 hours from last-seen-normal and meeting other AHA guidelines. Non-thrombolysis treated patients: includes aspirin 325 mg on day 1, then aspirin 81 mg or 325 mg thereafter, will be determined by treating physician and standard deep venous thrombosis prevention therapy. Intravenous anticoagulation and dual anti-platelet therapy will be discouraged without clear documented reasoning. Post-thrombolysis patients will be treated based on standard study site protocols. | 68 | None | 129 | 178 | 77 | 178 | View |
| Medical Management | Medical Management: Patients will receive standard AHA guideline-directed medical therapy, which will include IV thrombolytic therapy available for use according to practice guidelines in patients presenting within the first 3 hours from last-seen-normal and meeting other FDA label criteria, or up to 4.5 hours from last-seen-normal and meeting other AHA guidelines. For non-thrombolysis treated patients, this will include aspirin 325 mg on day 1 followed by aspirin 81 mg or 325 mg thereafter, which will be determined by treating physician and standard deep venous thrombosis prevention therapy. Intravenous anticoagulation and dual anti-platelet therapy will be discouraged without clear documented reasoning. Post-thrombolysis patients will be treated based on standard study site protocols for these patients. | 71 | None | 123 | 174 | 59 | 174 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Access Site Complication - Arterial Occlusion | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Access Site Complication - Hematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Access Site Complication - Infection | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Acute Arterial Occlusion (Acute Limb Ischemia) | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Cerebral Edema with Midline Shift | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cerebritis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| COVID-19 | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Deep Vein Thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Delirium, Cognitive Dysfunction | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Endocarditis | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Heart failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hyperglycemic Hyperosmolar State | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Lower respiratory infection (pneumonia) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Myocardial infarction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Neurological Deterioration | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| New Stroke | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Pericardial effusion | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Progression of Disease, Palliative Care Decision | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Pulmonary embolism | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Respiratory failure | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Sepsis, Systemic inflammatory response syndrome | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Symptomatic Intracranial Hemorrhage | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Urinary Tract Infection | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Wound Infection | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Alcohol Withdrawal | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Asymptomatic Intracranial Hemorrhage | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cardiac Arrythmia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Carotid Cavernous Fistula | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cerebral Vasospasm | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Clonus | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Diaphoresis | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Evolution of infarction on the brain imaging | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Eye Complications | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Fall | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Gastrointestinal Complications | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hallucination | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Ileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Lactose intolerance reaction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Laryngeal Edema | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Lethargy | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Liver Injury | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Musculoskeletal Complications | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| near syncopal episode | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Non-Cerebral Thrombotic Events | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| ocular nerve damage | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Other Renal Complications | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Progression of Disease | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| SDH | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Seizures | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Skin Complications | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Splenic infarct | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Stent Thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Symptomatic Carotid Artery Stenosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Syndrome of inappropriate ADH production | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Thirst | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Tinnitus | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Tremors | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Upper Respiratory Infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Uterine hemorrhage | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Vessel dissection | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Vessel perforation | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Epidural Hemorrhage | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |